Mysize newest ATM Machine...The American Stock Market.
Sure seems like it. I don't trust them. Caveat Emptor.
Read this:
My Size, Inc.
$6,000,000
3,000,000 Shares of Common Stock
Warrants to Purchase up to 1,500,000 Shares of Common Stock
We are offering 3,000,000 shares of our common stock and warrants to purchase up to 1,500,000 shares of our common stock, at an exercise price of $2.65 per share (the “Warrants”), pursuant to this prospectus supplement and the accompanying prospectus.
Our common stock is listed on The Nasdaq Capital Market under the symbol “MYSZ” and on the Tel Aviv Stock Exchange (“TASE”) under the symbol “MYSZ”. On January 30, 2018, the last reported sale price of our common stock on The Nasdaq Capital Market was $2.40 per share. There is no established public trading market for the Warrants being offered hereby and we do not expect a market to develop. In addition, we do not intend to apply for a listing of the Warrants on any national securities exchange. Without an active trading market, the liquidity of the Warrants will be limited.
Pursuant to General Instruction I.B.6 of Form S-3, in no event will we sell securities in a public primary offering with a value of more than one-third of the aggregate market value of our common stock held by non-affiliates in any twelve-month period, so long as the aggregate market value of our common stock held by non-affiliates remains below $75,000,000. The aggregate market value of our outstanding common stock held by non-affiliates pursuant to General Instruction I.B.6 of Form S-3 was approximately $56,721,361, which was calculated based on 25,716,927 shares of common stock outstanding, as of January 30, 2018, of which 19,832,644 shares were held by non-affiliates, and a price per share of $2.86 which was the closing sale price of our common stock on The Nasdaq Capital Market on January 8, 2018. Other than the shares of common stock and the Warrants offered pursuant to this prospectus supplement, we have not offered any securities pursuant to General Instruction I.B.6. of Form S-3 during the prior 12 calendar month period that ends on and includes the date hereof.
Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page S-5 of this prospectus for a discussion of information that should be considered in connection with an investment in our securities.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
We have engaged Roth Capital Partners, LLC as our exclusive placement agent in connection with this offering. The placement agent is not purchasing the securities offered by us and is not required to sell any specific number or dollar amount of securities but will assist us in this offering on a commercially reasonable “best efforts” basis. See “Plan of Distribution” beginning on Page 36 of this prospectus for more information regarding these arrangements. There is no minimum purchase requirement for this offering. We have agreed to pay the placement agent the placement agent fee set forth in the table below, which assumes that we sell all of the securities we are offering.
